Skip to main content

Predicting Treatment Quality in Children and Adolescents with Congenital Adrenal Hyperplasia Using Insulin and Renin

In brief

Insulin and renin flagged undertreatment in congenital adrenal hyperplasia with 80% accuracy

In 233 visits among 81 children and adolescents with congenital adrenal hyperplasia, a model combining insulin and renin correctly classified treatment status in 80% of cases. It detected 71% of undertreated patients and correctly ruled out undertreatment in 84%, but the score needs further validation before it can guide care beyond existing monitoring.

Journal
European journal of endocrinology (Q1)
Published
16 November 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Eva Ammann, Philipp E Augsburger, Ozair Abawi, Suzanne E Smit, Sabine E Hannema, Christiaan de Bruin, et al.
PMID
43035830
DOI
10.1093/ejendo/lvag208

Why clinicians should know about it

  • Picked for Biochemistry (medical) (top studies of the week, 22 November 2026): Routine insulin and renin inform biochemical monitoring of congenital adrenal

Abstract

BACKGROUND: Monitoring treatment quality in congenital adrenal hyperplasia (CAH) remains challenging. Current approaches rely predominantly on bone age and serum steroid measurements, which are variable and require expert interpretation. Reliable, accessible biochemical indicators are lacking. OBJECTIVE: To develop and evaluate a predictive score for undertreatment in children and adolescents with CAH using routinely available clinical and non-steroid laboratory parameters. METHODS: We conducted a prospective, multicenter cohort study including 81 patients with genetically confirmed 21-hydroxylase deficiency across four European pediatric endocrinology centers. Clinical features and laboratory parameters-including fasting insulin, renin, lipid profile, glucose, and growth indices-were assessed at three outpatient visits. Treatment status (optimal, undertreatment, overtreatment) was classified by expert endocrinologists. Logistic regression analyses were performed to identify predictors of undertreatment and to construct a predictive model. RESULTS: Data from 233 visits were analyzed. Undertreated patients showed significantly higher insulin (p = 0.005), higher renin (p = 0.003), increased height SDS (p = 0.014), and lower HDL cholesterol (p = 0.007) compared with optimally treated patients. The final predictive model retained insulin (coefficient 1.15) and renin (1.038) as independent predictors. At a threshold of ≥30-36, sensitivity was 71%, specificity 84%and overall correct classification 80%. The ROC curve yielded an AUC of 0.785. CONCLUSION: Serum insulin and renin, two inexpensive and routinely measured parameters, predict undertreatment in children and adolescents with CAH with good accuracy. Their dual relevance for short-term treatment monitoring and long-term cardiometabolic risk underscores their potential as practical tools to complement current strategies.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.